Marketplace for Molecules
Boehringer Ingelheim's openMe platform enables open access research .
Search
Data Privacy-Pharmacovigilance in Animal Health
Data Privacy Notice for Pharmacovigilance in Animal Health
More Potential: Overview
Society continues to face challenges ranging from health to education, work prospects, living conditions, inequalities and poverty, often impacting vulnerable communities the most.
Women in STEM: Passion for science to achieve more sustainable healthcare solutions
Women in STEM: Passion for science to achieve more sustainable healthcare solutions
Drug discovery Boehringer Ingelheim
Every day, scientists at Boehringer Ingelheim embark on a journey. It is a journey that can take up to 15 years and requires significant investment. Only a tiny proportion of these journeys are successful.
Boehringer Ingelheim Office Hours 2024: Shaping the Future of Innovation in Europe
Boehringer Ingelheim is actively supporting the next generation of innovators.
Interstitial Lung Diseases - Sound the ILD Alarm
Learn more about ILDs and why it's important to ‘sound the ILD alarm’ for early detection and treatment.
Improving the current state of schizophrenia care
A closer look at the status of the schizophrenia care landscape, an often misunderstood mental health condition
Data Protection Notice Medical Inquiries
Data Protection Notice Medical Inquiries
Making sustainable medicines through eco-design
Our goal is to minimize the environmental footprint of our medicines through integration of eco-design and green chemistry across the entire lifecycle
New cancer research building: Boosting innovation in oncology
With our new cancer research building in Vienna, we’ll advance our oncology pipeline and strengthen our commitment to innovation and collaboration.
Privacy Notice
Privacy Notice
Always Here – Our Commitment for Ukraine
Boehringer Ingelheim has actively supported Ukrainian civilians throughout the Russian invasion.